Tsilimigras et al reported the LabScore to evaluate patients with intrahepatic cholangiocarcinoma. This can help to identify a patient who may benefit from more aggressive management. The authors are from multiple institutions from around the world.
Patient selection: intrahepatic cholangiocarcinoma
Outcome: overall survival following resection
Parameters:
(1) serum CA19-9 in U/mL
(2) neutrophil-to-lymphocyte ratio (NLR)
(3) platelet count in 10^3/µL (10^9/L)
(4) serum albumin in g/dL
LabScore =
= (1.45 * LN(CA19-9)) + (0.84 * (NLR)) + (0.03 * (platelet count)) - (2.83 * (albumin)) + 8.2
LabScore
5-Year Overall Survival
0 to 9
55%
10 to 19
38%
>= 20
22%
Performance:
• The area under the ROC curve is 0.70 for the derivation and 0.67 in the validation cohorts.
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
